Sonoma Pharmaceuticals Launches Advanced Burn Relief Hydrogel in CVS and Walmart
Sonoma Pharmaceuticals launched its advanced HOCl-based burn relief hydrogel in CVS and Walmart stores nationwide, marking its first large-scale consumer burn product. The partnership leverages Sonoma’s hypochlorous acid technology platform to extend its U.S. retail presence following its 2025 diaper rash hydrogel debut.
1. Retail Launch
Sonoma Pharmaceuticals introduced its HOCl-based burn relief hydrogel into CVS and Walmart stores nationwide, marking the company’s first major consumer-focused burn care product. This launch builds on the successful mass-retail debut of its diaper rash hydrogel in 2025.
2. Product Details
The non-irritating hydrogel is indicated for minor burns and skin irritations, designed to soothe damaged skin and support natural healing using stabilized hypochlorous acid technology. Its formulation caters to everyday consumer needs, including seasonal sunburn care.
3. Expansion Strategy
Commercialization is executed through a U.S.-based distribution partner servicing CVS and Walmart, aligning with Sonoma’s strategy of leveraging strategic partnerships to broaden retail reach. This move underscores the company’s focus on innovation, regulatory compliance, and scalable manufacturing.